ArtBlood, a biotechnology company specializing in transfusion blood production, announced that it has signed a Memorandum of Understanding (MOU) with Expression Manufacturing LLC ("Expression"), the manufacturing subsidiary of Expression Therapeutics, Inc., to collaborate on the clinical development and large-scale production of in vitro-produced blood.
News
ArtBlood Signs MOU with Expression Manufacturing for Large-Scale In Vitro Red Blood Cell Production in Ohio
Published: April 08, 2025
Related Articles
Foreign Direct Investment
Bayer to Invest $2.2 Billion in a New Manufacturing Site in Ohio
Read More
((external link))
Business Climate
From a small-town pledge to the big time: A quest to turn central Ohio into a biotech hub
Read More
((external link))
Business Climate
Building a workforce engine for biomanufacturing
Read More
((external link))